Evaluation of the Structural Integrity of Layered Double Hydroxides and Mesoporous Silica During the Preparation of Heterostructures

Heterostructures constructed with mesoporous silica and layered double hydroxides are interesting for catalytic and drug delivery applications. Different arrangements between these phases are possible. In this study, we prepared heterostructures by embedding layered double hydroxides phases [M4Al2(OH)12](CO3) (M = Mg2+ or Zn2+) within the MCM41 mesoporous silica type phase. According to our results, the most critical step of this preparation is the removal of the organic template used to create the mesopores in the silica phase, which can be done by calcination or extraction with solvent, normally a mixture of ethanol and a mineral acid. The results reported in this study demonstrate that both can cause structural changes in the components of the heterostructure at different extensions. Calcination promoted the collapse of the layered hydroxide phases. Attempts made for their reconstruction through rehydration, which is a quite known process, were not completely effective and also dependent on the chemical composition of the layered phase. The complete template removal with preservation of the layered phases was possible using the extraction method but by replacing the mineral acid with NH4Cl. However, some discrete structural changes were identified possibly due to a partial lixiviation of Al3+ from the double hydroxide layers.</div

Structural, Spectroscopic (NMR, IR, and Raman), and DFT Investigation of the Self-Assembled Nanostructure of Pravastatin-LDH (Layered Double Hydroxides) Systems

Layered double hydroxide (LDH) nanocontainers, suitable as carriers for anionic drugs, were intercalated with Pravastatin drug using magnesium–aluminum and zinc–aluminum in a M^II/Al molar ratio equal 2 and different Al³⁺/Pravastatin molar ratios. Postsynthesis treatments were used in order to increase the materials crystallinity. Hybrid materials were characterized by a set of physical chemical techniques: chemical elemental analysis, X-ray diffraction (XRD), mass coupled thermal analyses, vibrational infrared and Raman spectroscopies, and solid-state ¹³C nuclear magnetic resonance (NMR). Results were interpreted in light of computational density functional theory (DFT) calculations performed for Sodium Pravastatin in order to assign the data obtained for the LDH intercalated materials. XRD peaks of LDH-Pravastatin material and the one-dimensional (1D) electron density map pointed out to a bilayer arrangement of Pravastatin in the interlayer region, where its associated carboxylate and vicinal hydroxyl groups are close to the positive LDH. The structural organization observed for the stacked assembly containing the unsymmetrical and bulky monoanion Pravastatin and LDH seems to be promoted by a self-assembling process, in which local interactions are maximized and chloride ion cointercalation is required. It is observed a high similarity among vibrational and ¹³C NMR spectra of Na-Pravastatin and LDH-Pravastatin materials. Those features indicate that the intercalation preserves the drug structural integrity. Spectroscopic techniques corroborate the nature of the guest species and their arrangement between the inorganic layers. Changes related to carboxylate, alcohol, and olefinic moieties are observed in both vibrational Raman and ¹³C NMR spectra after the drug intercalation. Thus, Pravastatin ions are forced to be arranged as head to tail through intermolecular hydrogen bonding between adjacent organic species. The thermal decomposition profile of the hybrid samples is distinct of that one observed for Na-Pravastatin salt, however, with no visible increase in the thermal behavior when the organic anion is sequestrated within LDH gap